| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $745K | — |
| SG&A Expense | $1.2M | +1530.1% |
| Operating Income | -$3.0M | -1294.6% |
| Net Income | -$3.3M | -1418.5% |
| EPS (Basic) | -$0.06 | -500.0% |
| EPS (Diluted) | -$0.06 | -500.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $107K | — |
| Current Assets | $114K | — |
| Total Assets | $114K | — |
| Current Liabilities | $1.0M | +210.5% |
| Total Liabilities | $1.0M | +210.5% |
| Stockholders' Equity | -$697K | -530.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | -3379.7% |
| Financing Cash Flow | $1.8M | +4647.2% |